Chair (W2) of Radioimmunology combined with the position of a head of department at the HZDR – 2026/75 Part-time

Chair (W2) of Radioimmunology Combined with the Position of a Head of Department at the HZDR

TUD Dresden University of Technology (TUD), as a University of Excellence, is one of the leading and most dynamic research institutions in the country. As an important part, the Faculty of Medicine and the University Hospital Dresden work closely together in partnership and are committed to excellence in cutting-edge medicine, medical research and teaching, and patient care for the entire region. The University Medicine Dresden sees itself as a modern employer and offers attractive working conditions to all employees in teaching, research and patient care, technology and administration and thus promotes and develops their potential. TUD embodies a university culture that is characterized by cosmopolitanism, mutual appreciation, thriving innovation and active participation. For TUD diversity is an essential feature and a quality criterion of an excellent university. Accordingly, we welcome all applicants who would like to commit themselves, their achievements and productivity to the success of the whole institution.

The Carl Gustav Carus Faculty of Medicine at TUD Dresden University of Technology and the Helmholtz-Zentrum Dresden-Rossendorf e. V. (HZDR) invite applications for the Chair (W2) of Radioimmunology combined with the position of a head of department at the HZDR in a joint appointment procedure to be filled at the earliest possible date.

The chair is based at the Department of Radiation Therapy and Radiooncology at the Carl Gustav Carus University Hospital in combination with the position of Head of the Department of Radioimmunology at the Institute of Radiopharmaceutical Cancer Research of Helmholtz-Zentrum Dresden-Rossendorf e. V. (HZDR).

As member of the Helmholtz Association of German Research Centers, the HZDR employs about 1,500 people. The HZDR's focus is on interdisciplinary research in the areas of energy, health and matter. The Institute of Radiopharmaceutical Cancer Research is engaged in multidisciplinary radiopharmaceutical cancer research. The radiochemistry, radiopharmacology, and physics research groups at the institute focus on developing and evaluating radiolabeled compounds for oncological PET/CT and SPECT/CT imaging, as well as exploring targeted approaches for endoradionuclide and (radio)immunotherapy in tumor diseases.

The scope of the chair includes the strategic development of the Department of Radioimmunology at the HZDR. This includes the preclinical and translational development and validation of antibodies, antibody derivatives, and chimeric antigen receptor (CAR) T cells for innovative immuno- and radioimmunotherapeutic strategies. It further includes compounds suitable for imaging-based characterization of pharmacokinetics and the targeting of molecular structures. The department is also responsible for developing preclinical test models, including 2D and 3D cell models and animal models. Additional research questions include modulating the tumor microenvironment to enhance the efficacy of the above-mentioned therapeutic approaches.

Close collaboration with clinical and basic research partners at the site plays a particularly important role, especially with the National Center for Tumor Diseases Dresden (NCT/UCC) and OncoRay—the National Center for Radiation Research in Oncology.

The chair will be responsible for teaching in the field of radioimmunology/radioimmunotherapy and is integrated into the Medical Radiation Science program with a reduced teaching load (2 course hours per semester). This includes conducting courses, developing and refining research-oriented teaching concepts, supervising doctoral and master's theses, and providing structured support for early-career researchers.

We are looking for you (m/f/x) as a professional with proven expertise, ideally in the following research areas:

• Development and evaluation of novel (humanized) antibodies and antibody derivatives for radioimmunotheranostics, with a particular focus on radioimmunotherapy
• Development and evaluation of novel adapter CAR T-cell systems, including adapter CAR T cells and adapter target molecules, for (radio)immunotherapy
• Establishment of novel preclinical in vitro and in vivo test models, including 2D and 3D cell models as well as animal models

You also have proven expertise and practical experience in the field of preclinical development of radioimmunotherapies with a strong translational focus. You demonstrate your outstanding academic achievements through internationally recognized publications and the successful acquisition of competitive external funding.

We expect you to possess strong collaboration and networking skills, particularly the ability to actively continue and further expand close cooperation with the aforementioned partners, as well as with various research groups at Dresden University Hospital—especially in the fields of hematology and oncology—and the Faculty of Medicine at TUD. We expressly hope that you are willing to work closely with clinicians, regulatory bodies, and networks (such as Clusters4Future SaxoCell) to translate the developed concepts into clinical application.

You have extensive experience and teaching skills in implementing modern, analog, and digital teaching approaches that inspire our students We also welcome your commitment to promoting and training young scientists. Strong leadership and diversity skills, particularly your management experience and your ability to strategically develop interdisciplinary teams, round off your profile.

We expect you to have completed a university degree in biology, chemistry, medicine or a related field, as well as a doctorate and habilitation or equivalent qualifications. In all other respects, the requirements for appointment, the official duties and the administrative status are governed by §§ 59, 69, 71 of the Act on Higher Education Institutions in the Free State of Saxony (SächsHSG) and the Regulations on Duties and Responsibilities at Higher Education Institutions (HSDAVO).

The Faculty of Medicine strives to employ more women professors in academia and research. We therefore expressly encourage women to apply. The University is a certified family-friendly university and offers a Dual Career Service. We welcome applications from candidates with disabilities. If multiple candidates prove to be equally qualified, those with disabilities or with equivalent status pursuant to the German Social Code IX (SGB IX) will receive priority for employment. If you have any questions about these topics, please contact the Equal Opportunities Officer of the Faculty of Medicine (Mrs. Katja El-Armouche, phone +49 351-458-16354) or of the HZDR (Mrs. Dr. Sandra Hamann, Tel. 0351-260-3649) and the representative for persons with disabilities of the Faculty of Medicine (Mrs. Vogelbusch, +49 351-458-12127) or of the HZDR (Mr. Dr. Frank Bok, Tel. 0351-260-3551).

We look forward to receiving your application by 5th July 2026 (preferably in electronic form in a single PDF file) or in hardcopy to Dekanin der Medizinischen Fakultät Carl Gustav Carus der Technischen Universität Dresden, Frau Prof. Dr. med. Dr. Esther Troost, Fetscherstr. 74, 01307 Dresden (medberufungen@mailbox.tu-dresden.de). If applying by post, please also enclose your application documents in electronic form (CD or USB storage device). Further information on the documents to be submitted can be found on the website of the Faculty of Medicine under the heading Job Offers. (https://tu-dresden.de/med/mf/die-fakultaet/stellenangebote/hinweise).